HomeCompareSLRC vs HRC

SLRC vs HRC: Dividend Comparison 2026

SLRC yields 11.67% · HRC yields 11.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HRC wins by $2.21M in total portfolio value
10 years
SLRC
SLRC
● Live price
11.67%
Share price
$14.05
Annual div
$1.64
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.2K
Annual income
$2,420.32
Full SLRC calculator →
HRC
HRC
● Live price
11.38%
Share price
$155.96
Annual div
$17.74
5Y div CAGR
40.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.26M
Annual income
$1,423,429.65
Full HRC calculator →

Portfolio growth — SLRC vs HRC

📍 HRC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSLRCHRC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SLRC + HRC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SLRC pays
HRC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SLRC
Annual income on $10K today (after 15% tax)
$992.17/yr
After 10yr DRIP, annual income (after tax)
$2,057.27/yr
HRC
Annual income on $10K today (after 15% tax)
$966.88/yr
After 10yr DRIP, annual income (after tax)
$1,209,915.20/yr
At 15% tax rate, HRC beats the other by $1,207,857.93/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SLRC + HRC for your $10,000?

SLRC: 50%HRC: 50%
100% HRC50/50100% SLRC
Portfolio after 10yr
$1.15M
Annual income
$712,924.98/yr
Blended yield
62.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SLRC right now

SLRC
Analyst Ratings
9
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$16.25
+15.7% upside vs current
Range: $16.00 — $16.50
Altman Z
0.5
Piotroski
4/9
HRC
Analyst Ratings
7
Buy
12
Hold
1
Sell
Consensus: Hold
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SLRC buys
0
HRC buys
0
No recent congressional trades found for SLRC or HRC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSLRCHRC
Forward yield11.67%11.38%
Annual dividend / share$1.64$17.74
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.3%
Portfolio after 10y$43.2K$2.26M
Annual income after 10y$2,420.32$1,423,429.65
Total dividends collected$17.8K$2.14M
Payment frequencyquarterlyquarterly
SectorBDCStock
Analyst consensusBuyHold

Year-by-year: SLRC vs HRC ($10,000, DRIP)

YearSLRC PortfolioSLRC Income/yrHRC PortfolioHRC Income/yrGap
1← crossover$11,867$1,167.26$12,296$1,595.93$429.00HRC
2$13,993$1,294.60$15,730$2,573.05$1.7KHRC
3$16,399$1,426.58$21,147$4,316.00$4.7KHRC
4$19,109$1,562.51$30,235$7,608.15$11.1KHRC
5$22,148$1,701.65$46,615$14,263.36$24.5KHRC
6$25,542$1,843.27$78,712$28,834.27$53.2KHRC
7$29,317$1,986.64$148,063$63,841.01$118.7KHRC
8$33,500$2,131.05$315,890$157,462.80$282.4KHRC
9$38,121$2,275.83$778,498$440,495.17$740.4KHRC
10$43,209$2,420.32$2,256,422$1,423,429.65$2.21MHRC

SLRC vs HRC: Complete Analysis 2026

SLRCBDC

SLR Investment Corp. is a business development company specializing in secured debt (first lien unitranche and second lien), subordinated (unsecured) debt, minority equity, leveraged buyouts, acquisitions, recapitalizations, general refinancing, growth capital and strategic income-oriented control equity investments in leveraged middle market companies. The fund invests in aerospace and defense; air freight & logistics; asset management; automotive; banking; beverage, food and tobacco; building products; buildings and real estate; broadcasting and entertainment; cargo transport; commercial services and supplies; communications equipment; chemicals, plastics and rubber; containers, packaging and glass; construction & engineering; diversified/conglomerate manufacturing; consumer Finance; distributors; diversified/conglomerate services; diversified financial services; diversified real estate activities; food products; Footwear; Education Services; diversified telecommunications services; electronics; farming and agriculture; finance; grocery; health care equipment and supplies; health care facilities; education and childcare; home and office furnishing, durable consumer products; hotels, motels, inns and gaming; insurance; restaurants, leisure, amusement, and entertainment; leisure equipment tolls and services, media, multiline retail, multi sector holdings; paper and forest products; personal products; professional services, research and consulting services, software; specialty retail; textiles apparel and luxury goods, thrifts and mortgage finance, trading companies and distributors, utilities, and wireless telecommunication services; industrial conglomerates; internet software and services, IT services, machinery; mining, steel, iron, and non-precious metals; oil and gas; personal, food and miscellaneous services; printing and publishing; retail stores; telecommunications; textiles and leather; and utilities. It also invests in life sciences with focus on specialty pharmaceuticals, medical devices, biotech, health Care Providers and services; health Care technology, enabling technologies and tools. The fund primarily invests in United States. The fund's investments generally range between $5 million and $100 million. The fund invests in companies with revenues between $50 million and $1 billion and EBITDA between $15 million and $100 million. It invests in the form of senior secured loans, mezzanine loans, and equity securities. It may also seek investments in thinly traded public companies and also make secondary investments. The fund makes non-control equity investments. It primarily exits within three years of the initial capital commitment.

Full SLRC Calculator →

HRCStock

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates in Patient Support Systems, Front Line Care, and Surgical Solutions segments. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as patient exam and diagnostics, patient monitoring, diagnostic cardiology, vision screening, and diagnostics products; and respiratory health products comprising Vest System, VitalCough System, MetaNeb System, Monarch, and Life2000 systems to assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables. Further, it is involved in the sales and rental of products to acute and extended care facilities through direct sales force and distributors; sales and rental of products directly to patients in the home; and sales to primary care facilities through distributors. Additionally, the company offers continuum of clinical care, including acute care and primary care, as well as clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois.

Full HRC Calculator →
📬

Get this SLRC vs HRC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SLRC vs SCHDSLRC vs JEPISLRC vs OSLRC vs KOSLRC vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.